images crypto- Top People also ask

In the first 11 months of GEM, the scale of raising funds by issuing 34 new shares dropped significantly year-on-year. Statistics show that from January to November, 2024, there were 34 new shares listed on GEM, with a total amount of raised funds of about 20.174 billion yuan. The number of issues and the scale of raising funds decreased by about 67% and 83% respectively year-on-year, and the number of listed new shares declined for three consecutive years. Among them, Nova Nebula and Yilian Technology have raised a total of more than 1 billion yuan, which is on the top. The share prices of the first-time shares of GEM all rose on the first day of listing, among which Changlian Technology and Shangda Shares rose more than 1000% on the first day of listing. In addition, there are 17 new shares listed income increased by more than 200%. In terms of underwriters, in the first November of 2024, the number of main underwriting projects of CITIC Jiantou, Guotai Junan and CICC was in the top three. Judging from the scale of fundraising, the total number of projects underwritten by Minsheng Securities and CITIC Jiantou exceeds 2.5 billion yuan, and the project scale of China Merchants Securities, Huatai United Securities and Guotai Junan exceeds 1.5 billion yuan. (Xinhua Finance)[In November, the global sales of pure electric and plug-in hybrid vehicles exceeded 1.8 million, with China accounting for 70%. According to the data released by market research company Rho Motion on Friday, the global sales of pure electric and plug-in hybrid vehicles increased for the seventh consecutive month in November, with a year-on-year increase of 32.3%, reaching 1.83 million, the third consecutive month reaching a record high. Among them, the sales of pure electric and plug-in hybrid vehicles in China market increased by 50%, reaching 1.27 million vehicles, accounting for nearly 70% of the total global sales.The yen once fell to 152.74 against the US dollar, and the trend fluctuated after the release of the Bank of Japan's short-term survey. After the release of the Bank of Japan's short-term survey, the yen initially rose slightly, but then weakened. The yen once fell 0.1% against the US dollar to 152.74. The 10-year Japanese government bond futures rose 4 points to 142.49.

Full-page observation of People's Daily: Accelerate the construction of world-class universities and advantageous disciplines with China characteristics.Futures on the Nikkei Stock Exchange of Singapore opened down 175 points to 39,635.BlackRock suggested that investors should consider allocating up to 2% in Bitcoin. BlackRock, an asset management company, reported that interested investors are advised to consider allocating up to 2% of their portfolio in Bitcoin. "We believe that investors with proper management ability and risk tolerance have reason to include Bitcoin in multi-asset portfolios," BlackRock's four-member senior management team pointed out in the report. Team members include Samara Cohen, Chief Investment Officer of ETF, and Paul Henderson, Senior Portfolio Strategist of BlackRock Investment Institute.

The Australian stock market fell for the fourth consecutive trading day, led by mining stocks. The Australian stock market fell with the US stock market on Friday, with mining stocks falling the most. The day before, the unemployment rate in Australia fell sharply in November, prompting investors to reduce their bets on interest rate cuts in February. Australia's S&P/ASX 200 index fell 0.7% to 8276.5, the fourth consecutive trading day. The benchmark fell by about 1.6% this week, the biggest weekly decline since early August.Futures on the Nikkei Stock Exchange of Singapore opened down 175 points to 39,635.Onlikon: The cooperative product Aidit calcitonin soft capsules is planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13th, and on December 12th, the company received a notice from its partner Beijing Meifurun Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Meifurun") that the Aidit calcitonin soft capsules jointly developed by the company and its wholly-owned subsidiary Wenzhou Haihe Pharmaceutical Co., Ltd. are planned to be selected for the tenth batch of national centralized drug procurement. According to the Pharmaceutical Cooperation Agreement signed by the company and its partner Mei Furun, the company owns 50% of the cooperative products.